Articles by Disease (Neuroblastoma)

Alzheimer’s Disease and Antioxidant Therapy: How Long How Far?

Journal: Current Medicinal Chemistry
Volume: 20
Page: 2939-2952
Author(s): J. Teixeira, T. Silva, P. B. Andrade and F. Borges

Targets for Anti-metastatic Drug Development

Journal: Current Pharmaceutical Design
Volume: 19
Page: 5127-5134
Author(s): Anna-Maria Stock, Gabriele Troost, Bernd Niggemann, Kurt S. Zanker and Frank Entschladen

Potential Roles of HDAC Inhibitors in Mitigating Ischemia-induced Brain Damage and Facilitating Endogenous Regeneration and Recovery

Journal: Current Pharmaceutical Design
Volume: 19
Page: 5105-5120
Author(s): Emily B. Fessler, Fairouz L. Chibane, Zhifei Wang and De-Maw Chuang

The Bioanalytical Molecular Pharmacology of the N-methyl-_D-Aspartate (NMDA) Receptor Nexus and the Oxygen-Responsive Transcription Factor HIF-1α : Putative Mechanisms and Regulatory Pathways Unravel the Intimate Hypoxia Connection

Journal: Current Molecular Pharmacology
Volume: 6
Page: 104-135
Author(s): John J. Haddad

Antimicrobial Photodynamic Therapy to Kill Gram-negative Bacteria

Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 8
Page: 108-120
Author(s): Felipe F. Sperandio, Ying-Ying Huang and Michael R. Hamblin

New Molecular Targets in the Treatment of NSCLC

Journal: Current Pharmaceutical Design
Volume: 19
Page: 5333-5343
Author(s): Clorinda Schettino, Maria Anna Bareschino, Paola Claudia Sacco, Paolo Maione, Antonio Rossi, Francesca Casaluce, Assunta Sgambato and Cesare Gridelli

Resveratrol and Cancer Treatment: Is Hormesis a Yet Unsolved Matter?

Journal: Current Pharmaceutical Design
Volume: 19
Page: 5384-5393
Author(s): Adriana Borriello, Debora Bencivenga, Ilaria Caldarelli, Annunziata Tramontano, Alessia Borgia, Anna Virginia Adriana Pirozzi, Adriana Oliva and Fulvio Della Ragione